跳至主要内容
临床试验/NL-OMON48923
NL-OMON48923
已完成
不适用

An fMRI and EEG study in patients with mild to moderate Alzheimer*s disease and healthy elderly controls - fMRI and EEG study in Alzheimer patients

Centre for Human Drug Research0 个研究点目标入组 24 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Alzheimer's Disease
发起方
Centre for Human Drug Research
入组人数
24
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
去年
研究类型
Observational invasive

研究者

入排标准

入选标准

  • 1\. Aged 50\- 80 years;
  • 2\. Ability to communicate well with the investigator in the Dutch language;
  • 3\. Willing to give written informed consent and to comply with the study
  • restrictions;
  • Additional inclusion criteria for the AD subjects are:
  • 4\. Diagnosed with probable AD according to the National Institute of
  • Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease
  • and Related Disorders Association (NINCDS\-ADRDA) criteria confirmed by the
  • treating physician;
  • 5\. MMSE score 18\-26 (inclusive);

排除标准

  • 1\. Any contra\-indications for MRI (prostheses, implants, claustrophobia,
  • pacemakers, etc.);
  • 2\. Presence or history of alcohol abuse, or daily alcohol consumption exceeding
  • 2 standard drinks per day on average for females or exceeding 3 standard drinks
  • per day on average for males (1 standard drink \= 10 grams of alcohol), or a
  • positive breath alcohol test at screening or upon admission to the Clinical
  • Research Unit (CRU);
  • 3\. Use of tobacco and/or nicotine\-containing products within 30 days of day 1;
  • 4\. Positive urine drug screen at screening or day 1;
  • 5\. Unable to refrain from use of (methyl) xanthine (e.g. coffee, tea, cola,

结局指标

主要结局

未指定

相似试验